SAFETY ASPECTS OF GENE THERAPY
- 1 April 1992
- journal article
- review article
- Published by Wiley in British Journal of Haematology
- Vol. 80 (4), 421-426
- https://doi.org/10.1111/j.1365-2141.1992.tb04552.x
Abstract
No abstract availableThis publication has 53 references indexed in Scilit:
- No Retroviremia or Pathology in Long-Term Follow-Up of Monkeys Exposed to a Murine Amphotropic RetrovirusHuman Gene Therapy, 1991
- Steady ProgressHuman Gene Therapy, 1991
- Efficient Packaging of a Specific VL30 Retroelement by Ψ2 Cells Which Produce MoMLV Recombinant RetrovirusesHuman Gene Therapy, 1990
- Applications of the Polymerase Chain Reaction in Retroviral-Mediated Gene Transfer and the Analysis of Gene-Marked Human TIL CellsHuman Gene Therapy, 1990
- Amphotropic Murine Leukemia Retrovirus Is Not an Acute Pathogen for PrimatesHuman Gene Therapy, 1990
- Chromosome 17 Deletions and p53 Gene Mutations in Colorectal CarcinomasScience, 1989
- Expression of human adenosine deaminase in nonhuman primates after retrovirus-mediated gene transfer.The Journal of Experimental Medicine, 1987
- Suppression of leukaemia virus pathogenicity by polyoma virus enhancersNature, 1985
- Cellular origin and role of mink cell focus-forming viruses in murine thymic lymphomasNature, 1982
- Lymphomagenicity of recombinant mink cell focus-inducing murine leukemia viruses.The Journal of Experimental Medicine, 1980